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Background: Since the publication of the “FAME” study, the use of the pressure wire has increased. Intravenous adenosine (IV) is considered the 
standard method to measure the fractional flow reserve (FFR).
Methods: A comparative study between two methods. Different incremental doses of intracoronary adenosine (50, 150, 300, and 500 μg as bolus) 
vs. a standard intravenous infusion of 140 μg /kg/min. Maximal hyperemia was defined as the lowest FFR measured between the two methods.
Results: FFR was assessed in 44 patients with 54 lesions during cardiac catheterization. FFR decreased significativally (p<0.05) with increasing 
intracoronary adenosine doses(IC): Bolus means FFR: 0.86±0.06 (50μg), 0.85±0.06 (150μg), and 0.84±0.06 (300 μg). There were no differences 
between 300 and 500 μg boluses. There were significant differences between the FFR IV and FFR IC with 300 pg: 0.86±0.06 vs.0.84±0.06, p=0.01. 
The 50 μg bolus IC failed to diagnose 6 out of 54 (11.1%) significant stenoses. The IV failed to diagnose 3 out of 53 (5.6%) significant stenosis. 
The agreement between the two sets of measurements (300 pg IC vs. IV) was high, and the Kappa index value was 0.89 (p = 0.05). AV blocks was 
associated with de incremental IC bolus doses: 50 pg (0%), 150 pg (9.3%), 300 pg (20.4%) and 500 pg (29.6%). IC boluses were well tolerated, 
with fewer systemic adverse effects (only 1 patient present with symptomatic AV block), than intravenous adenosine (12p, 22.2% presented 
dysphea). One patient in the IV group, had severe side effects (bronchospasm and severe nausea), FFR could not be measured in this patient. The 
procedures were shorter in the IC group, with fewer minutes of test (2.80±0.7 IC vs. 6.3±1.4 IV; p=0.001).
Conclusion: The administration of very high intracoronary adenosine bolus is safe and well tolerated, and shortens the procedure. Furthermore 
intracoronary administration of 300 pg adenosine produced a more pronounced hyperemia than intravenous adenosine and may be the preferred 
mode of application for the assessment of FFR.
